Travere Therapeutics
TVTX
TVTX
116 hedge funds and large institutions have $691M invested in Travere Therapeutics in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
13% less funds holding
Funds holding: 133 → 116 (-17)
47% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 36
Holders
116
Holding in Top 10
8
Calls
$61.1M
Puts
$40.2M
Top Buyers
| 1 | +$12.5M | |
| 2 | +$7.14M | |
| 3 | +$7.12M | |
| 4 |
BC
Broadfin Capital
New York
|
+$6.75M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$6.5M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$6.06M | |
| 3 | -$6.01M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.88M |
| 5 |
Morgan Stanley
New York
|
-$4.75M |